Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. 2014

J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
Group Health Research Institute 1730 Minor Ave , Suite 1600, Seattle, WA 98101-1448.

OBJECTIVE We evaluated the role of home monitoring, communication with pharmacists, medication intensification, medication adherence and lifestyle factors in contributing to the effectiveness of an intervention to improve blood pressure control in patients with uncontrolled essential hypertension. METHODS We performed a mediation analysis of a published randomized trial based on the Chronic Care Model delivered over a secure patient website from June 2005 to December 2007. Study arms analyzed included usual care with a home blood pressure monitor and usual care with home blood pressure monitor and web-based pharmacist care. Mediator measures included secure messaging and telephone encounters; home blood pressure monitoring; medications intensification and adherence and lifestyle factors. Overall fidelity to the Chronic Care Model was assessed with the Patient Assessment of Chronic Care (PACIC) instrument. The primary outcome was percent of participants with blood pressure (BP) <140/90 mm Hg. RESULTS At 12 months follow-up, patients in the web-based pharmacist care group were more likely to have BP <140/90 mm Hg (55%) compared to patients in the group with home blood pressure monitors only (37%) (p = 0.001). Home blood pressure monitoring accounted for 30.3% of the intervention effect, secure electronic messaging accounted for 96%, and medication intensification for 29.3%. Medication adherence and self-report of fruit and vegetable intake and weight change were not different between the two study groups. The PACIC score accounted for 22.0 % of the main intervention effect. CONCLUSIONS The effect of web-based pharmacist care on improved blood pressure control was explained in part through a combination of home blood pressure monitoring, secure messaging, and antihypertensive medication intensification.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D017008 Negotiating The process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy. Arbitrating,Mediating,Arbitration,Conflict Resolution,Mediation,Negotiation,Conflict Resolutions,Negotiations,Resolution, Conflict
D017216 Telemedicine Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Tele-Care,Tele-ICU,Tele-Intensive Care,Tele-Referral,Telecare,Virtual Medicine,Mobile Health,Telehealth,eHealth,mHealth,Health, Mobile,Medicine, Virtual,Tele Care,Tele ICU,Tele Intensive Care,Tele Referral,Tele-Referrals

Related Publications

J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
January 2011, Hypertension (Dallas, Tex. : 1979),
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
July 2015, Journal of the American Society of Hypertension : JASH,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
October 2021, Journal of clinical nursing,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
January 2011, Hypertension (Dallas, Tex. : 1979),
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
March 2008, Journal of human hypertension,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
July 2011, Archives of internal medicine,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
December 2008, Nature clinical practice. Cardiovascular medicine,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
January 2012, American journal of hypertension,
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
August 2012, Hypertension (Dallas, Tex. : 1979),
J D Ralston, and A J Cook, and M L Anderson, and S L Catz, and P A Fishman, and J Carlson, and R Johnson, and B B Green
January 2001, Journal of clinical hypertension (Greenwich, Conn.),
Copied contents to your clipboard!